Regulatory Science Series
Innovative evidence generation for regulatory decision making
The Regulatory Science Series shares ongoing efforts at IQVIA to develop and utilize innovative approaches to assess the performance of regulated products. They feature details on case examples and lessons learned in advancing novel use of real world data, real world evidence, clinical trial design, digital health technologies, drug safety, and post-market surveillance to help bring regulated products to market.